Palatin Technologie Aktie
WKN DE: 915470 / ISIN: US6960773041
03.01.2018 13:38:59
|
Palatin Reports FDA's Acceptance Of IND Application For PL-8177 - Quick Facts
(RTTNews) - Palatin Technologies, Inc. (PTN) announced the U.S. FDA has notified the company that it may proceed with its clinical investigation of subcutaneous injection PL-8177 as a potential treatment for patients with ulcerative colitis. The notice to proceed was received following Palatin's submission of an investigational new drug application for the program.
Palatin expects to commence a Phase 1 single and multiple ascending dose study in the current quarter.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Palatin Technologie Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |